Literature DB >> 21952096

Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis.

M B D'hooghe1, P Haentjens, G Nagels, M Garmyn, J De Keyser.   

Abstract

BACKGROUND: Sunlight and vitamin D have been inversely associated with the risk of multiple sclerosis (MS).
OBJECTIVE: We investigated sunlight exposure and sun sensitivity in relation to disability progression in MS.
METHODS: We conducted a survey among persons with MS, registered by the Flemish MS society, Belgium, and stratified data according to relapsing-onset and progressive-onset MS. We used Kaplan-Meier survival and Cox proportional hazard regression analyses with time to Expanded Disability Status Scale (EDSS) 6 as outcome measure. Hazard ratios for the time from onset and from birth were calculated for the potentially predictive variables, adjusting for age at onset, gender and immunomodulatory treatment.
RESULTS: 704 (51.3%) of the 1372 respondents had reached EDSS 6. In relapsing-onset MS, respondents reporting equal or higher levels of sun exposure than persons of the same age in the last 10 years had a decreased risk of reaching EDSS 6. In progressive-onset MS, increased sun sensitivity was associated with an increased hazard of reaching EDSS 6.
CONCLUSION: The association of higher sun exposure with a better outcome in relapsing-onset MS may be explained by either a protective effect or reverse causality. Mechanisms underlying sun sensitivity might influence progression in progressive-onset MS.

Entities:  

Mesh:

Year:  2011        PMID: 21952096     DOI: 10.1177/1352458511423778

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  5 in total

1.  Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?

Authors:  Anja Mähler; Silvia Mandel; Mario Lorenz; Urs Ruegg; Erich E Wanker; Michael Boschmann; Friedemann Paul
Journal:  EPMA J       Date:  2013-02-18       Impact factor: 6.543

2.  Epidemiology of multiple sclerosis in Qom: Demographic study in Iran.

Authors:  Saeed Rezaali; Ahad Khalilnezhad; Abdorreza Naser Moghadasi; Samira Chaibakhsh; Mohammad Ali Sahraian
Journal:  Iran J Neurol       Date:  2013

3.  Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up.

Authors:  Anne-Hilde Muris; Joost Smolders; Linda Rolf; Lieke J J Klinkenberg; Noreen van der Linden; Steven Meex; Jan Damoiseaux; Raymond Hupperts
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

4.  Predictors of progression from a first demyelinating event to clinically definite multiple sclerosis.

Authors:  Caron Chapman; Robyn M Lucas; Anne-Louise Ponsonby; Bruce Taylor
Journal:  Brain Commun       Date:  2022-07-09

5.  Activities of daily living and lesion position among multiple sclerosis patients by Bayes network.

Authors:  Zhifang Pan; Hongtao Lu; Qi Cheng
Journal:  Neural Regen Res       Date:  2013-05-15       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.